Cargando…

PS152. Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies

Detalles Bibliográficos
Autores principales: Eriksson, Hans, Weiller, Emmanuelle, Weiss, Catherine, Zhang, Peter, Skuban, Aleksandar, Thase, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616748/
http://dx.doi.org/10.1093/ijnp/pyw043.152
_version_ 1783266855659503616
author Eriksson, Hans
Weiller, Emmanuelle
Weiss, Catherine
Zhang, Peter
Skuban, Aleksandar
Thase, Michael E.
author_facet Eriksson, Hans
Weiller, Emmanuelle
Weiss, Catherine
Zhang, Peter
Skuban, Aleksandar
Thase, Michael E.
author_sort Eriksson, Hans
collection PubMed
description
format Online
Article
Text
id pubmed-5616748
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56167482017-11-27 PS152. Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies Eriksson, Hans Weiller, Emmanuelle Weiss, Catherine Zhang, Peter Skuban, Aleksandar Thase, Michael E. Int J Neuropsychopharmacol Abstracts Oxford University Press 2016-05-27 /pmc/articles/PMC5616748/ http://dx.doi.org/10.1093/ijnp/pyw043.152 Text en © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
spellingShingle Abstracts
Eriksson, Hans
Weiller, Emmanuelle
Weiss, Catherine
Zhang, Peter
Skuban, Aleksandar
Thase, Michael E.
PS152. Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies
title PS152. Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies
title_full PS152. Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies
title_fullStr PS152. Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies
title_full_unstemmed PS152. Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies
title_short PS152. Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies
title_sort ps152. efficacy and safety of brexpiprazole (opc-34712) as adjunctive treatment in major depressive disorder: meta-analysis of two pivotal studies
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616748/
http://dx.doi.org/10.1093/ijnp/pyw043.152
work_keys_str_mv AT erikssonhans ps152efficacyandsafetyofbrexpiprazoleopc34712asadjunctivetreatmentinmajordepressivedisordermetaanalysisoftwopivotalstudies
AT weilleremmanuelle ps152efficacyandsafetyofbrexpiprazoleopc34712asadjunctivetreatmentinmajordepressivedisordermetaanalysisoftwopivotalstudies
AT weisscatherine ps152efficacyandsafetyofbrexpiprazoleopc34712asadjunctivetreatmentinmajordepressivedisordermetaanalysisoftwopivotalstudies
AT zhangpeter ps152efficacyandsafetyofbrexpiprazoleopc34712asadjunctivetreatmentinmajordepressivedisordermetaanalysisoftwopivotalstudies
AT skubanaleksandar ps152efficacyandsafetyofbrexpiprazoleopc34712asadjunctivetreatmentinmajordepressivedisordermetaanalysisoftwopivotalstudies
AT thasemichaele ps152efficacyandsafetyofbrexpiprazoleopc34712asadjunctivetreatmentinmajordepressivedisordermetaanalysisoftwopivotalstudies